🔬 Confidential Sample Analysis for Medical Device Manufacturers

Discover the true ageing behaviour of your materials—without revealing your secrets.

At Gulsine Ltd, we are now offering a limited campaign exclusively for Medical Device Manufacturers (MDMs): confidential analysis of your proprietary or undisclosed materials to determine key ageing parameters, including Activation Energy (Ea) and Q10 values.

You send us samples of a material you know well—no disclosure of composition or formulation is required. Using our A2P2 methodology, we will extract scientifically validated indicators of the material’s long-term behaviour under physiological or storage conditions.

You will receive a concise technical report outlining:

  • The activation energy (Ea) of the dominant ageing mechanism

  • The Q10 ageing acceleration factor

  • High-resolution master curves and mechanical degradation profiles

  • Key ageing insights based on the Gulsine ageing risk matrix

This will help your R&D, regulatory, and materials science teams better understand:

  • How quickly the material may degrade in-use or in storage

  • Whether current ageing test protocols are under- or over-conservative

  • How your material compares against industry benchmarks

Your material identity remains strictly confidential—we only focus on what the material does, not what it is.

This is a wonderful opportunity to explore the power of A2P2 science, without altering your current validation processes. Gain deeper insight into the performance of your material under real-world stress and temperature conditions—in just a few days.

Interested?
Contact us or submit a request through our secure portal. Places are limited.

🎯 Short-Time Offer for MDMs:

Unlock Hidden Ageing Insights—Without Revealing Your Material!
For a limited time only, Gulsine invites medical device manufacturers to participate in an exclusive, confidential ageing analysis campaign.

Don't miss this unique opportunity to scientifically assess your materials' long-term behaviour—no disclosure required.